ArticleMikrochimica acta2026
Use of organ-on-chip devices and single particle ICP-MS for assessing dynamic in vitro bioavailability of silver and titanium dioxide nanoparticles from foodstuff.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The most common way to study the cellular transport of nutrients and pollutants when simulating intestinal absorption is to use static in vitro models. However, these approaches are limited by the lack of dynamism in simulating the intestinal absorption process, and they fail to consider the stress created by fluid during this process. The development of micro-physiological systems, such as organ-on-a-chip (OoC), enables the dynamics of the process to be incorporated into the simulation, offering a more realistic approach. This research has studied the potential for using an OoC with Caco-2 cells to simulate the intestinal absorption of inorganic silver and titanium dioxide nanoparticles in food additives (E171) and food, e.g. sugar pearls containing the food additive E174 and seafood, -seaweed and mussels which were exposed to nanoparticles in controlled laboratory trials. A viable cell monolayer was achieved under flow conditions for 96 h using the commercial μ-Slide I Luer 3D microfluidic device. This made possible to carry out cell transport experiments on the bio-accessible fractions obtained from the samples under study. The nanoparticle content (particle number concentration) and particle size distribution were obtained using inductively coupled plasma mass spectrometry working in the single particle mode (spICP-MS). This technique is of great importance to monitor particle size changes given the agglomeration and/or dissolution phenomena that nanoparticles undergo depending on the surrounding environment. To study these processes, complementary techniques such as transmission electron microscopy, were used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.